
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
B, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma
Departments of 1 Pathology, 2 Biochemistry, and 3 Surgery, Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong
Purpose: Nuclear factor
B (NF-
B) signaling pathway is an important regulating pathway in human diseases and cancers. One of its downstream target genes is urokinase plasminogen activator (uPA), which is involved in cancer invasion and metastasis. The purpose of this study was to evaluate NF-
B activation, uPA up-regulation, and hepatitis B viral X protein (HBx) expression in human hepatocellular carcinoma (HCC) and to assess their clinicopathological significance.
Experimental Design: We evaluated NF-
B activation, expression of uPA, and presence of HBx in 32 human HCCs. Their clinicopathological significance was assessed by correlation with the clinicopathological features. Aberrant NF-
B signaling pathway and uPA up-regulation mediated by HBx were also analyzed in vitro.
Results: We found that NF-
B activation and uPA up-regulation were frequently (56% and 59%, respectively) observed in HCCs, and particularly in HBx-positive HCCs. NF-
B activation and uPA overexpression were closely associated with one another (P < 0.0001). Furthermore, both activation of NF-
B and up-regulation of uPA were significantly associated with a more aggressive tumor behavior in terms of venous invasion, direct liver invasion, and absence of tumor encapsulation. In vitro, NF-
B activation was induced by HBx transfection in HepG2 cells through inhibitor of nuclear factor-
B kinase ß (IKKß). HBx also up-regulated uPA and enhanced cell invasion synergistically with IKKß.
Conclusions: The data indicate that NF-
B dysregulation and uPA overexpression may lead to a more aggressive tumor behavior in HCC. In addition, our data suggest that IKKß plays a critical role in the HBx-activated NF-
B signaling pathway.
This article has been cited by other articles:
![]() |
T. K. Lee, R. T.P. Poon, J. Y. Wo, S. Ma, X.-Y. Guan, J. N. Myers, P. Altevogt, and A. P.W. Yuen Lupeol Suppresses Cisplatin-Induced Nuclear Factor-{kappa}B Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model Cancer Res., September 15, 2007; 67(18): 8800 - 8809. [Abstract] [Full Text] [PDF] |
||||
![]() |
N H Park, I H Song, and Y-H Chung Chronic hepatitis B in hepatocarcinogenesis. Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueno, D. Aoki, F. Kubo, K. Hiwatashi, K. Matsushita, T. Oyama, I. Maruyama, and T. Aikou Roxithromycin Inhibits Constitutive Activation of Nuclear Factor {kappa}B by Diminishing Oxidative Stress in a Rat Model of Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2005; 11(15): 5645 - 5650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |